Metropolitan Life Insurance Company (MetLife)’s EVO Payments, Inc. Class A Common Stock EVOP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-2,853
| Closed | -$96.5K | – | 2513 |
|
|
2022
Q4 | $96.5K | Hold |
2,853
| – | – | ﹤0.01% | 1065 |
|
|
2022
Q3 | $95K | Sell |
2,853
-345
| -11% | -$10.7K | ﹤0.01% | 1049 |
|
|
2022
Q2 | $75.2K | Hold |
3,198
| – | – | ﹤0.01% | 1239 |
|
|
2022
Q1 | $73.8K | Sell |
3,198
-9,733
| -75% | -$231K | ﹤0.01% | 1383 |
|
|
2021
Q4 | $331K | Hold |
12,931
| – | – | ﹤0.01% | 1687 |
|
|
2021
Q3 | $306K | Buy |
+12,931
| New | +$343K | ﹤0.01% | 1755 |
|
|
2021
Q2 | – | Sell |
-12,339
| Closed | -$340K | – | 2921 |
|
|
2021
Q1 | $340K | Hold |
12,339
| – | – | 0.01% | 1672 |
|
|
2020
Q4 | $333K | Hold |
12,339
| – | – | 0.01% | 1619 |
|
|
2020
Q3 | $307K | Hold |
12,339
| – | – | 0.01% | 1526 |
|
|
2020
Q2 | $282K | Hold |
12,339
| – | – | 0.01% | 1587 |
|
|
2020
Q1 | $189K | Buy |
12,339
+1,650
| +15% | +$40.7K | ﹤0.01% | 1622 |
|
|
2019
Q4 | $282K | Hold |
10,689
| – | – | ﹤0.01% | 1677 |
|
|
2019
Q3 | $301K | Buy |
10,689
+2,277
| +27% | +$66.8K | 0.01% | 1610 |
|
|
2019
Q2 | $265K | Hold |
8,412
| – | – | ﹤0.01% | 1705 |
|
|
2019
Q1 | $244K | Hold |
8,412
| – | – | ﹤0.01% | 1770 |
|
|
2018
Q4 | $208K | Hold |
8,412
| – | – | ﹤0.01% | 1797 |
|
|
2018
Q3 | $201K | Buy |
+8,412
| New | +$192K | ﹤0.01% | 2009 |
|
Other funds holding EVOP
Metropolitan Life Insurance Company (MetLife)'s EVOP Position: Q1 2023 in Review
Metropolitan Life Insurance Company (MetLife) sold out of EVO Payments, Inc. Class A Common Stock (EVOP) in Q1 2023, closing a stake of 2,853 shares — an estimated $96.5K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in EVOP in Q3 2018 and held it in 17 quarters. The position peaked at $340K in Q1 2021. 1 fund tracked by Wall St. Rank holds EVOP as of Q1 2023.
- Metropolitan Life Insurance Company (MetLife) reported no remaining EVO Payments, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 2,853 EVO Payments, Inc. Class A Common Stock shares in Q1 2023, an estimated $96.5K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in EVO Payments, Inc. Class A Common Stock in Q3 2018 and held it in 17 quarters.
- Metropolitan Life Insurance Company (MetLife)'s EVO Payments, Inc. Class A Common Stock position peaked at $340K in Q1 2021.
- 1 fund tracked by Wall St. Rank held EVO Payments, Inc. Class A Common Stock as of Q1 2023.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2023, filed 15 May 2023.